Vaccine manufacturing is lumpy, supply not as good as hoped, UK says

Published
0

Britain's vaccine rollout is limited by a “lumpy” manufacturing process with production changes by Pfizer and a delay by AstraZeneca that could lead to brief supply disruption, Vaccine Deployment Minister Nadhim Zahawi said.

Zahawi told LBC radio that the United Kingdom was hoping for two million vaccines a week from AstraZeneca but that those numbers will not be reached until mid February. Still, he said the UK was on course to hit its rollout targets.

“It's been a bit lumpy,” Zahawi said of vaccine manufacture. Pfizer will temporarily reduce its deliveries to Europe of its vaccine against Covid-19 while it upgrades its production capacity, according to Reuters.

“There's bound to be delays. Any new manufacturing process has challenges at the outset, it is lumpy, it begins to stabilise and get better and better week in, week out,” Zahawi told the BBC.

Opinion

Editorial

After the talks
Updated 05 Oct, 2026

After the talks

Considering how close they came to a solution, govt and opposition teams should reconvene to give the talks another chance.
Child safety online
Updated 05 Oct, 2026

Child safety online

Pakistani children are spending more of their lives online, but the safeguards around them are not keeping pace.
Rising public debt
05 Oct, 2026

Rising public debt

Pakistan’s public debt has surged by 76pc to Rs86.7tr in four years, according to a new government report.
Yemen offensive
Updated 04 Oct, 2026

Yemen offensive

The best option, therefore, is for Muslim and Arab states to help restore the Saudi-Houthi ceasefire.
Growth transition
04 Oct, 2026

Growth transition

PRIME Minister Shehbaz Sharif’s recent call to move from stabilisation to growth, job creation and export ...
Protection at risk
04 Oct, 2026

Protection at risk

THE recent warning from UNHCR should alarm donor governments. Nearly 8.3m refugees and other forcibly displaced...